The Efficacy and Safety of Proton Pump Inhibitors Combining Dual Antiplatelet Therapy in Patients with Coronary Intervention: A Systematic Review, Meta-Analysis and Trial Sequential Analysis of Randomized Controlled Trials

The Efficacy and Safety of Proton Pump Inhibitors Combining Dual Antiplatelet Therapy in Patients with Coronary Intervention: A Systematic Review, Meta-Analysis and Trial Sequential Analysis of Randomized Controlled Trials

Background: Proton pump inhibitors (PPIs) are used to prevent gastrointestinal hemorrhage in patients with coronary treatment undergoing dual antiplatelet therapy (DAPT). Methods: A systematic review was performed to compare the outcomes between DAPT and DAPT + PPI in acute coronary syndrome (ACS) p...

Full description

Bibliographic Details
Main Authors:	Shichu Liang, Min Ma, Yonghao Chen, Jing Zhang, Jing Li, Shenglin Jiang, Yaoqun Wang, He Huang, Yong He
Format:	Article
Language:	English
Published:	IMR Press 2023-08-01
Series:	Reviews in Cardiovascular Medicine
Subjects:	proton pump inhibitors acute coronary syndrome meta-analyses dual antiplatelet therapy sequential trial analysis
Online Access:	https://www.imrpress.com/journal/RCM/24/8/10.31083/j.rcm2408230

Similar Items

Concomitant Use of Antiplatelet Agents and Proton-Pump Inhibitors Increases the Risk of Adverse Cardiovascular Events: A Nationwide Population-Based Cohort Study Using Balanced Operational Definitions
by: Hee Gyu Yang, et al.
Published: (2023-06-01)

The effects of proton pump inhibitors on the development of post-stenting major adverse cardiovascular events in patients with acute coronary syndrome
by: Yigit Oguz Unal, et al.
Published: (2023-06-01)

Best duration of dual antiplatelet therapy after drug-eluting stent implantation: an updated network meta-analysis of randomized controlled trials
by: Mahmoud Barbarawi, et al.
Published: (2019-01-01)

Dual Antiplatelet Therapy: A Concise Review for Clinicians
by: Hafeez Ul Hassan Virk, et al.
Published: (2023-07-01)

Inappropriate Use of Proton Pump Inhibitors Increases Cardiovascular Events in Patients with Coronary Heart Disease
by: Hu W, et al.
Published: (2022-12-01)

ANTIPLATELET THERAPY IN PATIENTS WITH HIGH RISK OF THROMBOTIC EVENTS: THE PROBLEM OF EFFICIENCY, SAFETY AND COMPLIANCE
by: S. Yu. Martsevich, et al.
Published: (2014-07-01)

ANTIPLATELET THERAPY IN PATIENTS WITH HIGH RISK OF THROMBOTIC EVENTS: THE PROBLEM OF EFFICIENCY, SAFETY AND COMPLIANCE
by: S. Yu. Martsevich, et al.
Published: (2014-07-01)

PROLONGED DUAL ANTIPLATELET THERAPY AFTER MYOCARDIAL INFARCTION: WHAT THE RESULTS OF THE PEGASUS-TIMI 54 TRIAL SHOW
by: I. S. Yavelov
Published: (2017-09-01)

A dual role of proton pump inhibition on cancer: a critical review
by: Edizer Deniz Tuna, et al.
Published: (2023-02-01)

A meta-analysis and trial sequential analysis of high intensity focused ultrasound ablation combined with transhepatic arterial chemotherapy and embolization for hepatoma
by: Liang Zhang, et al.
Published: (2022-10-01)

Trial sequential analysis: novel approach for meta-analysis
by: Hyun Kang
Published: (2021-04-01)

Proton pump inhibitors overuse: only inappropriate prescriptions or further iatrogenic damage?
by: Mario Visconti
Published: (2015-09-01)

Proton pump inhibitor has no effect in the prevention of post-endoscopic sphincterotomy delayed bleeding: a prospective randomized controlled trial
by: Zhengping Yu, et al.
Published: (2023-06-01)

Pooled Analysis of Bleeding, Major Adverse Cardiovascular Events, and All‐Cause Mortality in Clinical Trials of Time‐Constrained Dual‐Antiplatelet Therapy After Percutaneous Coronary Intervention
by: John D. McClure, et al.
Published: (2020-08-01)

Early Surgery with Neuraxial Anaesthesia in Patients on Chronic Antiplatelet Therapy with a Proximal Femur Fracture: Multicentric Randomised Clinical Trial
by: Rafael Anaya, et al.
Published: (2021-11-01)

UP TO DATE ANTIPLATELET THERAPY IN PATIENTS WITH HIGH RISK OF THROMBOTIC EVENTS AND REAL CLINICAL PRACTICE
by: S. Yu. Martsevich, et al.
Published: (2015-12-01)

Role of proton pump inhibitor in healing after choanal atresia repair: a randomized control trial
by: Ahmed ElSalmawy, et al.
Published: (2022-04-01)

Proton pump inhibitors- Adversaries in our fight against antibiotic resistance?
by: Sumayya Umar, et al.
Published: (2023-10-01)

Fifteen-Year Nationwide Trend in Antiplatelet Treatment among Drug-Eluting Stent Recipients in Korea: Many Patients Receive Very Prolonged Dual-Antiplatelet Treatment, and Newer Drugs Are Replacing the Older Ones
by: Sunwon Kim, et al.
Published: (2023-04-01)

Comparison of the Degree of Gastric Mucosal Injury between Patients Who Are Receiving Dual Antiplatelet Therapy or Single Antiplatelet Therapy
by: Yuji Shimada, et al.
Published: (2022-09-01)

Efficacy and safety of concomitant use of proton pump inhibitors with aspirin-clopidogrel dual antiplatelet therapy in coronary heart disease: A systematic review and meta-analysis
by: Xiaofeng Luo, et al.
Published: (2023-01-01)

Antiplatelet Therapy Aims and Strategies in Asian Patients with Acute Coronary Syndrome or Stable Coronary Artery Disease
by: Chor-Cheung Tam, et al.
Published: (2022-12-01)

Proton pump inhibitors and dementia: what association?
by: Catarina Caetano, et al.
Published: (2023-05-01)

Dual Antiplatelet Therapy Regimens and Duration for Intracranial Stenting Procedures: Literature Review
by: Milda Paliulytė, et al.
Published: (2023-11-01)

DUAL ANTIPLATELET THERAPY IN THE REAL CLINICAL PRACTICE
by: G. N. Guseva, et al.
Published: (2015-09-01)

Thrombelastographic hypercoagulability and antiplatelet therapy after coronary artery bypass surgery (TEG-CABG trial): a randomized controlled trial
by: Sulman Rafiq, et al.
Published: (2017-11-01)

Strategies for discontinuation of proton pump inhibitors (PPIs) in patients with long-term PPI administration: a randomized controlled trial
by: Mariko Hojo, et al.
Published: (2022-01-01)

Vitamin D Supplementation for Patients with Dysmenorrhoea: A Meta-Analysis with Trial Sequential Analysis of Randomised Controlled Trials
by: Kan-Chu Lin, et al.
Published: (2024-04-01)

Meta-analysis and trial sequential analysis of ezetimibe for coronary atherosclerotic plaque compositions
by: Bofeng Chai, et al.
Published: (2023-03-01)

Safety and Potential Risks of Prolonged Use of Proton Pump Inhibitors
by: S.M. Tkach
Published: (2014-02-01)

Effects of proton pump inhibitor on gastroesophageal varices in patients with cirrhosis: A randomized controlled trial from China
by: Xiaoning Chen, et al.
Published: (2023-03-01)

De-escalation of antiplatelet therapy in acute coronary syndromes: Why, how and when?
by: Mattia Galli, et al.
Published: (2022-08-01)

Dual antiplatelet therapy in patients with acute coronary syndrome. Results of actual clinical practice
by: O. L. Barbarash, et al.
Published: (2018-11-01)

No Differences in Gastrointestinal Bleeding Risk among Clopidogrel-, Ticagrelor-, or Prasugrel-Based Dual Antiplatelet Therapy
by: Viviana Laredo, et al.
Published: (2020-05-01)

Absence of bleeding upon dual antiplatelet therapy in a patient with a immune GPVI deficiency
by: Stéphane Loyau Inserm, et al.
Published: (2021-07-01)

Antiplatelet Therapy in Acute Coronary Syndrome
by: I. M. Kuzmina, et al.
Published: (2022-01-01)

Proton-pump inhibitors
by: Vasudevan G. Naidoo
Published: (2015-05-01)

No association between myeloperoxidase gene rs2333227 G>A polymorphism and Alzheimer's disease risk: a meta-analysis and trial sequential analysis
by: Zhi-Cheng Fang, et al.
Published: (2022-01-01)

Proton Pump Inhibitors Use and Risk of Preeclampsia: A Meta-Analysis
by: Salman Hussain, et al.
Published: (2022-08-01)

Duration of Antiplatelet Therapy Following Transcatheter Aortic Valve Replacement: Systematic Review and Network Meta‐Analysis
by: Toshiki Kuno, et al.
Published: (2021-05-01)